Validation of a French version of Roland-Morris questionnaire in chronic low back pain patients.

Ann Phys Rehabil Med

Service de médecine physique et de réadaptation, CHU de Tours, 37170 Chambray lès Tours, France; Service de rhumatologie, CHC de Maisons-Laffitte, 78600 Maisons-Laffitte, France.

Published: December 2013

Objective: To validate a French version of the Roland-Morris Disability Questionnaire (RMDQ) in patients with chronic low back pain (LBP).

Material And Methods: Fifty-eight patients due to participate in a functional rehabilitation programme for chronic low back pain were included prospectively. The RMDQ, the Quebec Back Pain Disability Scale (QBPDS) and the "daily activities" subscale of the Dallas Pain Questionnaire (DPQ) were administered. The RMDQ was assessed for internal consistency, reliability, criterion validity and sensitivity to change.

Results: Cronbach's alpha for the RMDQ was 0.84. The intraclass correlation coefficient [95% confidence interval] was 0.89 [0.83-0.93]. The RMDQ score was correlated with the QBPDS score (r=0.713) and the DPQ's "daily activities" subscore (r=0.514). The results of assessments before and after functional rehabilitation showed that the French version of the RMDQ had very high sensitivity to change (effect size: 1.49) and was more sensitive than the QBPDS and the DPQ's "daily activities" subscore.

Conclusions: Our study validated the French version of the RMDQ in patients suffering from chronic low back pain. Furthermore, we highlighted the questionnaire's very high sensitivity to change.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rehab.2013.08.006DOI Listing

Publication Analysis

Top Keywords

french version
16
chronic low
16
low pain
16
"daily activities"
12
version roland-morris
8
rmdq patients
8
functional rehabilitation
8
dpq's "daily
8
version rmdq
8
high sensitivity
8

Similar Publications

Background And Objective: Limited information is available on the pharmacokinetics of rifampicin (RIF) along with that of its active metabolite, 25-deacetylrifampicin (25-dRIF). This study aimed to analyse the pharmacokinetic data of RIF and 25-dRIF collected in adult patients treated for tuberculosis.

Methods: In adult patients receiving 10 mg/kg of RIF as part of a standard regimen for drug-susceptible pulmonary tuberculosis enrolled in the Opti-4TB study, plasma RIF and 25-dRIF concentrations were measured at various occasions.

View Article and Find Full Text PDF

Objective: The Psychosocial Assessment Tool (PAT) is a brief caregiver report, family-centered, psychosocial risk screening tool widely used in pediatrics and available in many languages. Although French is an official language of Canada, a French-Canadian version of the PAT has not yet been validated, which impedes access to this tool for family psychosocial screening. This study aimed to translate, adapt as necessary, and validate the French-Canadian version of the PAT.

View Article and Find Full Text PDF

Impact of immersive virtual reality compared to a digital static approach in word (re)learning in post-stroke aphasia and neurotypical adults: lexical-semantic effects?

Neuropsychologia

January 2025

Faculty of Psychology and Educational Sciences, University of Geneva, 40 Boulevard du Pont d'Arve, 1205 Geneva, Switzerland. Electronic address:

Background: Word production difficulty is one of the most common and persisting symptoms in people suffering from aphasia (i.e., anomia).

View Article and Find Full Text PDF

There is still much room for improving the self-advocacy of elderly female patients with breast cancer. Subjects (168 in total) were selected from elderly female patients with breast cancer who had been hospitalized from May to December 2022 using the convenience sampling method. Assessment was conducted for the status quo of self-advocacy of subjects using the Chinese version of Female Self-Advocacy in Cancer Survivorship (FSACS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!